Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | ACHE | P22303 | 4/20 | 1.00 |
| ▸ | APEX1 | P27695 | 3/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | RAB9A | P51151 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.92 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.73 |
| ▸ | APAF1 | O14727 | 1/20 | 0.65 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.65 |
| ▸ | RAD52 | P43351 | 1/20 | 0.65 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30019398 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL6933263 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL17898629 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL17898630 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL6931794 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| Decamethonium SCHEMBL238400 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL8208718 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL12126378 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| Pentamethonium SCHEMBL61798 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 | |
| SCHEMBL12198121 | 1.00 | MEN1 (1.00) | MEN1KMT2AACHEAPEX1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11812 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743479-A1 | ADENOVIRUSES | Theolytics Ltd. (GB) | 2026-05-20 | — | — | EP | claimed |
| CN-122012815-A | Synchronous detection primer, probe and application of norovirus II, group A rotavirus and adenovirus | 安徽省公共卫生临床中心(安徽省传染病医院) | 2026-05-12 | — | — | CN | claimed |
| US-12623910-B2 | Molecular sieve SSZ-94, catalyst, and methods of use thereof | CHEVRON U.S.A. INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-20260117254-A1 | COMPOSITIONS AND METHODS FOR PREPARING VIRAL VECTORS | NIKEGEN LLC (US) | 2026-04-30 | — | — | US | claimed |
| US-20260117201-A1 | Polynucleotides for use in AAV production | ENCODED THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12611658-B2 | Molecular sieve SSZ-93, catalyst, and methods of use thereof | CHEVRON U.S.A. INC. (US) | 2026-04-28 | — | — | US | claimed |
| EP-4728440-A2 | IDENTIFYING MINIMUM-ENERGY RESONANCE REGION AT MAJORANA ISLAND | Microsoft Technology Licensing, LLC (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4705954-A2 | JOINT PARITY MEASUREMENTS OF MAJORANA ZERO MODES IN THE PRESENCE OF QUASIPARTICLE POISONING | Microsoft Technology Licensing, LLC (US) | 2026-03-11 | — | — | EP | claimed |
| US-20260042675-A1 | MOLECULAR SIEVE SSZ-91 WITH HIERARCHICAL POROSITY, METHODS FOR PREPARING, AND USES THEREOF | CHEVRON USA INC (US) | 2026-02-12 | — | — | US | claimed |
| EP-4689137-A1 | COMPOSITIONS AND METHODS FOR RECOMBINANT AAV PRODUCTION | REGENXBIO Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-5016652-A | Dermally Applicable Patch | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1991-05-21 | — | — | US | claimed |
| EP-0333769-A4 | COMBINATIONS OF RENAL VASODILATORS AND ALPHA 1-ADRENERGIC OR GANGLIONIC BLOCKING AGENTS FOR TREATING DISEASES. | NEW YORK MEDICAL COLLEGE (US) | 1990-06-27 | — | — | EP | claimed |
| US-4920989-A | Method and apparatus for aiding in the reduction of incidence of tobacco smoking | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1990-05-01 | — | — | US | claimed |
| EP-0333769-A1 | COMBINATIONS OF RENAL VASODILATORS AND ALPHA 1-ADRENERGIC OR GANGLIONIC BLOCKING AGENTS FOR TREATING DISEASES | NEW YORK MEDICAL COLLEGE (US) | 1989-09-27 | — | — | EP | claimed |
| WO-1988004179-A1 | COMBINATIONS OF RENAL VASODILATORS AND alpha1-ADRENERGIC OR GANGLIONIC BLOCKING AGENTS AND METHODS FOR TREATING DISEASES | NEW YORK MEDICAL COLLEGE (US) | 1988-06-16 | — | — | WO | claimed |
| US-4749686-A | Combinations of renal vasodilators and α1 -adrenergic or ganglionic blocking agents and methods for treating diseases | NEW YORK MEDICAL COLLEGE (US) | 1988-06-07 | — | — | US | claimed |
| US-4581376-A | ALPHA-ADRENERGIC ANTAGONISTS, HYPOTENSIVE AGENTS FOR GLAUCOMA AND DECONGESTANTS | MACRI FRANK J (US) | 1986-04-08 | — | — | US | claimed |
| US-4487829-A | Production and use of monoclonal antibodies against adenoviruses | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1984-12-11 | — | — | US | claimed |
| EP-0126327-A1 | Norepinephrine potentiated pharmaceutical composition, ophthalmic solution and kit containing the same | Macri, Frank J. (US) | 1984-11-28 | — | — | EP | claimed |
| EP-0051318-A1 | A catalyst composition containing as catalytically active components alumina and a cristalline Aluminosilicate zeolite, a process for isomerizing xylenes and ethylbenzene, and use of this catalyst composition | Teijin Petrochemical Industries Ltd. (JP) | 1982-05-12 | — | — | EP | claimed |